Author Correction: ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer
Christopher W Schultz, Yang Zhang, Rajaa Elmeskini, Astrid Zimmermann, Haiqing Fu, Yasuhisa Murai, Darawalee Wangsa, Suresh Kumar, Nobuyuki Takahashi, Devon Atkinson, Liton Kumar Saha, Chien-Fei Lee, Brian Elenbaas, Parth Desai, Robin Sebastian, Ajit Kumar Sharma, Melissa Abel
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsLung Cancer Research Studies · Cancer Mechanisms and Therapy · interferon and immune responses
Correction to: EMBO Molecular Medicine (2023) 15:e17313. 10.15252/emmm.202217313 | Published online 25 July 2023
By mutual agreement of all authors and by the evidence that the additional author meets the appropriate authorship criteria, Laura L Bassel and their contribution and authorship position will be added to this manuscript.
The authorship will be corrected from:
Christopher W Schultz^1^, Yang Zhang^1^, Rajaa Elmeskini^2^, Astrid Zimmermann^3^, Haiqing Fu^1^, Yasuhisa Murai^1^, Darawalee Wangsa^4^, Suresh Kumar^1^, Nobuyuki Takahashi^1,5^, Devon Atkinson^2^, Liton Kumar Saha^1^, Chien-Fei Lee^6^, Brian Elenbaas^6^, Parth Desai^1^, Robin Sebastian^1^, Ajit Kumar Sharma^1^, Melissa Abel^1^, Brett Schroeder^1^, Manan Krishnamurthy^1^, Rajesh Kumar^1^, Nitin Roper^1^, Mirit Aladjem^1^, Frank T Zenke^3^, Zoe Weaver Ohler^2^, Yves Pommier^1^, Anish Thomas^1^
To:
Christopher W Schultz^1^, Yang Zhang^1^, Rajaa Elmeskini^2^, Astrid Zimmermann^3^, Haiqing Fu^1^, Yasuhisa Murai^1^, Darawalee Wangsa^4^, Suresh Kumar^1^, Nobuyuki Takahashi^1,5^, Devon Atkinson^2^, Liton Kumar Saha^1^, Chien-Fei Lee^6^, Brian Elenbaas^6^, Parth Desai^1^, Robin Sebastian^1^, Ajit Kumar Sharma^1^, Melissa Abel^1^, Brett Schroeder^1^, Manan Krishnamurthy^1^, Laurel L Bassel^2^, Rajesh Kumar^1^, Nitin Roper^1^, Mirit Aladjem^1^, Frank T Zenke^3^, Zoe Weaver Ohler^2^, Yves Pommier^1^, Anish Thomas^1^
Author Statement:
Laura L Bassel, pathologist at the Center for Advanced Preclinical Research, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD, USA, contributed to the above cited paper by quantifying the IHC stain and necrosis in (panel E in emmm202217313-fig-0005ev): Reference figure: emmm202217313-fig-0005ev-m.jpg-EMBO Molecular Medecine 2023.jpg.